Investigational approaches to therapies for idiopathic pulmonary fibrosis

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.6, 2010-06, pp. : 737-745

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idiopathic Pulmonary Fibrosis: Pathogenesis and Therapeutic Approaches

By Selman M.

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 405-430

Adis International

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Investigational approaches to therapies for restless legs syndrome

By de Biase Stefano Merlino Giovanni Lorenzut Simone Valente Mariarosaria Gigli Gian Luigi

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 847-856

Informa Healthcare

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Emerging drugs for idiopathic pulmonary fibrosis

By Selman Moiséés Pardo Annie Richeldi Luca Cerri Stefania

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 341-362

Informa Healthcare

Access to resources Recommend Favorite